Cardio-ankle vascular index relates to left ventricular ejection fraction in patients with heart failure: A retrospective study

International Heart Journal

Volumn 54, Issue 4, 2013, Pages 216-221

  Zhang, Chengmin ^a   Ohira, Masahiro ^b   Iizuka, Takuo ^b   Mikamo, Hiroshi ^b   Nakagami, Takahiro ^b   Suzuki, Masayo ^b   Hirano, Keiichi ^b   Takahashi, Mao ^b   Shimizu, Kazuhiro ^b   Sugiyama, Yuko ^b   Yamaguchi, Takashi ^b   Kawana, Hidetoshi ^b   Endo, Kei ^b   Saiki, Atsuhito ^b   Oyama, Tomokazu ^b   Kurosu, Takumi ^b   Tomaru, Takanobu ^b   Wang, Hongyu ^c   Noike, Hirofumi ^b   Shirai, Kohji ^b  

^a Zichuan District Hospital   (China)

^b TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

^c PEKING UNIVERSITY SHOUGANG HOSPITAL   (China)

Author keywords

Afterload; Left ventricle ejection fraction

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ACUTE DISEASE; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIO ANKLE VASCULAR INDEX; CARDIOTHORACIC RATE; CARDIOVASCULAR PARAMETERS; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART AFTERLOAD; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MALE; MEDICAL PARAMETERS; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY;

EID: 84881295095     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.54.216     Document Type: Article

References (29)

1. Dicksteinc K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29: 2388-442. (Review)
2. Greenberg BH, Massie BM. Benefcial effects of afterload reduction therapy in patients with congestive heart failure and moderate aortic stenosis. Circulation 1980; 61: 1212-6.
3. Shirai K, Utino J, Otsuka K, Takata M. A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb 2006; 13: 101-7.
4. Kawasaki T, Sasayama S, Yagi S, Asakawa T, Hirai T. Non-invasive assessment of the age related changes in stiffness of major branches of the human arteries. Cardiovasc Res 1987; 21: 678-87.
5. Bramwell JC, Hill AV. The Velocity of the Pulse wave in Man. Proc Roy Soc 1922; 93: 298-306.
6. Buntin CM, Silver FH. Noninvasive assessment of mechanical properties of peripheral arteries. Ann Biomed Eng 1990; 18: 549-66.
7. Kubozono T, Miyata M, Ueyama K, et al. Clinical significance and reproducibility of new arterial distensibility index. Circ J 2007; 71: 89-94.
8. Yambe T, Yoshizawa M, Saijo Y, et al. Brachio-ankle pulse wave velocity and cardio-ankle vascular index (CAVI). Biomed Phar-macother 2004; 58 Suppl 1: 95-98. (Review)
9. Takaki A, Ogawa H, Wakeyama T, et al. Cardio-ankle vascular index is a new noninvasive parameter of arterial stiffness. Circ J 2007; 71: 1710-4.
10. Miyoshi T, Doi M, Hirohata S, et al. Cardio-ankle vascular index is independently associated with the severity of coronary atherosclerosis and left ventricular function in patients with ischemic heart disease. J Atheroscler Thromb 2010; 17: 249-58.
11. Malík J, Tuka V, Mokrejsová M, Holaj R, Tesar V. Mechanisms of chronic heart failure development in end-stage renal disease patients on chronic hemodialysis. Physiol Res 2009; 58: 613-21. (Review)
12. Chalmers J. The 1999 WHO-ISH Guidelines for the Management of Hypertension. Med J Aust 1999; 171: 458-9.
13. Teramoto T, Sasaki J, Ueshima H, et al. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb 2007; 14: 45-50. (Review)
14. Nagai Y, Kitagawa K, Yamagami H, et al. Carotid artery intima-media thickness and plaque score for the risk assessment of stroke subtypes. Ultrasound Med Biol 2002; 28: 1239-43.
15. Handa N, Matsumoto M, Maeda H, et al. Ultrasonic evaluation of early carotid atherosclerosis. Stroke 1990; 21: 1567-72.
16. Matsuura H, Murakami T, Hina K, et al. Association of elevated plasma B-type natriuretic peptide levels with paroxysmal atrial f-brillation in patients with nonobstructive hypertrophic cardiomy-opathy. Clin Biochem 2008; 41: 134-9.
17. Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiogra-phy). J Am Soc Echocardiogr 2003; 16: 1091-110. (Review)
18. Brandts A, van Elderen SG, Westenberg JJ, et al. Association of aortic arch pulse wave velocity with left ventricular mass and lacu-nar brain infarcts in hypertensive patients: assessment with MR imaging. Radiology 2009; 253: 681-8.
19. Sakane K, Miyoshi T, Doi M, et al. Association of new arterial stiffness parameter, the cardio-ankle vascular index, with left ventricular diastolic function. J Atheroscler Thromb 2008; 15: 261-8.
20. Cohn JN, Franciosa JA. Vasodilator therapy of cardiac failure: (first of two parts). N EngI J Med 1977; 297: 27-31. (Review)
21. Shirai K, Song M, Suzuki J, et al. Contradictory effects of β1- and α1- adrenergic receptor blockers on cardio-ankle vascular stiffness index (CAVI) -- CAVI independent of blood pressure. J Athero-scler Thromb 2011; 18: 49-55.
22. Nagayama D, Saiki A, Endo K, et al. Improvement of cardio-an-kle vascular index by glimepiride in type 2 diabetic patients. Int J Clin Pract 2010; 64: 1796-801.
23. Ohira M, Endo K, Oyama T, et al. Improvement of postprandial hyperglycemia and arterial stiffness upon switching from premixed human insulin 30/70 to biphasic insulin aspart 30/70. Metabolism 2011; 60: 78-85.
24. Miyashita Y, Endo K, Saiki A, et al. Effect of ezetimibe mono-therapy on lipid metabolism and arterial stiffness assessed by car-dio-ankle vascular index in type 2 diabetic patients. J Atheroscler Thromb 2010; 17: 1070-6.
25. Noike H, Nakamura K, Sugiyama Y, et al. Changes in cardio-an-kle vascular index in smoking cessation. J Atheroscler Thromb 2010; 17: 517-25.
26. Miyashita Y, Saiki A, Endo K, et al. Effects of olmesartan, an an-giotensin II receptor blocker, and amlodipine, a calcium channel blocker, on Cardio-Ankle Vascular Index (CAVI) in type 2 diabetic patients with hypertension. J Atheroscler Thromb 2009; 16: 621-6.
27. Miyashita Y, Endo K, Saiki A, et al. Effects of pitavastatin, a 3-hy-droxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardio-ankle vascular index in type 2 diabetic patients. J Atheroscler Thromb 2009; 16: 539-45.
28. Sasaki H, Saiki A, Endo K, et al. Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy. J Atheroscler Thromb 2009; 16: 568-75.
29. Nishimura RA, Tajik AJ. Evaluation of diastolic flling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J Am Coll Cardiol 1997; 30: 8-18. (Review)